Related Experiment Video
Updated: Aug 13, 2026
![Autoradiographic Measurements of [14C]-Iodoantipyrine in Rat Brain Following Central Post-Stroke Pain](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F53947.jpg&w=3840&q=50)
Autoradiographic Measurements of [14C]-Iodoantipyrine in Rat Brain Following Central Post-Stroke Pain
Published on: July 18, 2016
Carisoprodol concentrations from different anatomical sites: three overdose cases
R C Backer1, R Zumwalt, P McFeeley
1Office of the Medical Investigator, State of New Mexico, Albuquerque.
This study details three carisoprodol overdose cases. Carisoprodol and meprobamate levels were measured in biological samples using gas chromatography/mass spectrometry for forensic analysis.
Area of Science:
- Forensic Toxicology
- Pharmacology
Background:
- Carisoprodol is a muscle relaxant with potential for abuse and overdose.
- Understanding carisoprodol and its metabolite pharmacokinetics is crucial for clinical and forensic toxicology.
Observation:
- Three cases of carisoprodol overdose were documented.
- Biological samples (urine, blood, vitreous humor, heart) were collected from the cases.
- Carisoprodol and its primary metabolite, meprobamate, were the focus of analysis.
Findings:
- Gas chromatography/mass spectrometry (GC/MS) was employed for precise drug quantification.
- Concentrations of carisoprodol and meprobamate were determined across various biological matrices.
- The data provides quantitative insights into carisoprodol distribution and metabolism in overdose scenarios.
Implications:
- This case series contributes valuable quantitative data for interpreting carisoprodol and meprobamate levels in forensic investigations.
- The findings can aid in diagnosing and managing carisoprodol toxicity.
- GC/MS provides a reliable method for detecting and quantifying these substances in post-mortem and clinical toxicology.
Related Concept Videos
Prevention of Further Absorption of Poison
Drug Concentrations: Measurements
Plasma —...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Toxidromes: Clinical Features
Pharmaceutical Poisoning: Potential Scenarios

